[go: up one dir, main page]

AP2006003557A0 - Antimalarial compositions and process thereof. - Google Patents

Antimalarial compositions and process thereof.

Info

Publication number
AP2006003557A0
AP2006003557A0 AP2006003557A AP2006003557A AP2006003557A0 AP 2006003557 A0 AP2006003557 A0 AP 2006003557A0 AP 2006003557 A AP2006003557 A AP 2006003557A AP 2006003557 A AP2006003557 A AP 2006003557A AP 2006003557 A0 AP2006003557 A0 AP 2006003557A0
Authority
AP
ARIPO
Prior art keywords
antimalarial compositions
antimalarial
compositions
Prior art date
Application number
AP2006003557A
Inventor
Geena Malhotra
Amar Lulla
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AP2006003557A0 publication Critical patent/AP2006003557A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AP2006003557A 2003-09-04 2004-09-03 Antimalarial compositions and process thereof. AP2006003557A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN902MU2003 2003-09-04
PCT/GB2004/003748 WO2005023304A2 (en) 2003-09-04 2004-09-03 Antimalarial compositions and manufacturing process thereof

Publications (1)

Publication Number Publication Date
AP2006003557A0 true AP2006003557A0 (en) 2006-04-30

Family

ID=34259970

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003557A AP2006003557A0 (en) 2003-09-04 2004-09-03 Antimalarial compositions and process thereof.

Country Status (4)

Country Link
AP (1) AP2006003557A0 (en)
BR (1) BRPI0413767A (en)
WO (1) WO2005023304A2 (en)
ZA (1) ZA200602031B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0401107A (en) * 2004-04-13 2005-11-22 Fundacao Oswaldo Cruz Compounds derived from artesunate, process of preparing these compounds, pharmaceutical composition containing said compounds, use of the respective medicine in the treatment or prevention of malaria or other parasitic diseases and therapeutic method
FR2884715B1 (en) * 2005-04-20 2007-06-15 Sanofi Aventis Sa ASSOCIATION BETWEEN FERROQUIN AND AN ARTEMISININE DERIVATIVE FOR THE TREATMENT OF MALARIA
WO2007036947A1 (en) * 2005-09-30 2007-04-05 Ipca Laboratories Limited Delayed release anti-malarial composition
WO2007043061A1 (en) * 2005-10-11 2007-04-19 Ipca Laboratories Ltd. Anti-malarial combination and methods of formulation
CH696229A5 (en) * 2006-05-13 2007-02-28 Professeur Dr Achille Benakis New galenic forms of Artemisinin and its derivatives in combination with other antimalarials for the treatment of malaria.
FR2914860B1 (en) * 2007-04-12 2009-05-22 Ile D Inventeurs Apis Spheromo MULTILAYER SPHEROIDS WITH ANTIPALUDITIC ACTION IN WHICH ONE OF THE LAYERS CONTAINS ARTESUNATE
CN101756982B (en) * 2008-12-17 2012-07-04 重庆医药工业研究院有限责任公司 Artesunate compound medicine composition with improved mouth feeling and high stability
FR2951945B1 (en) * 2009-11-05 2013-08-09 Sanofi Aventis PHARMACEUTICAL COMPOSITION
WO2015041722A1 (en) * 2013-09-17 2015-03-26 Kryptonite Group, Ltd Enhanced artemisinin-based combination therapy for treating parasitic mediated disease
TWI733649B (en) * 2014-03-07 2021-07-21 巴哈馬商克利普頓集團公司 Enhanced artemisinin-based combination therapy for treating parasitic mediated disease
US20170326102A1 (en) * 2014-11-27 2017-11-16 Cipla Limited Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
CN107982227A (en) * 2017-12-05 2018-05-04 昆药集团股份有限公司 A kind of tablet of dihydroartemisinine and preparation method thereof
CN107982228B (en) * 2017-12-05 2022-08-16 昆药集团股份有限公司 Dihydroartemisinin tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria
ES2054975T3 (en) * 1988-10-07 1994-08-16 Hoechst Ag ANTIMALARIC COMPOSITIONS USING QUINIDINE, ARTEMISININ AND ITS DERIVATIVES.
CN1058717A (en) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 New antimalarial agent-Coartem and preparation method thereof
US20050148628A1 (en) * 2002-02-13 2005-07-07 Edgar Muller Pharmaceutical combination of artesunate and mefloquine for therapy of malaria

Also Published As

Publication number Publication date
WO2005023304A3 (en) 2005-07-07
ZA200602031B (en) 2007-05-30
BRPI0413767A (en) 2006-10-31
WO2005023304A2 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
AP2280A (en) Compositions and methods for increasing telomeraseactivity.
EP1646382A4 (en) Compounds, compositions and methods
EP1692112A4 (en) Compounds, compositions, and methods
AU2003262747A8 (en) Compounds, compositions, and methods
EP1664746A4 (en) Antioxodant sensor, methods and compositions
EP1503993A4 (en) Compounds, methods and compositions
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
AU2003270015A8 (en) Compounds, compositions, and methods
EP1617807A4 (en) Substituted 1,4-diazepines and uses thereof
AU2003299612A8 (en) Compounds, compositions and methods
IL164581A0 (en) Compounds, compositions and methods
IL172222A0 (en) Aryl-heteroaromatic products, compositions comprising them and use
AU2003277079A8 (en) Compounds, compositions, and methods
EP1594849A4 (en) Compounds, compositions, and methods
HUP0500871A3 (en) 5-aryltetrazole compounds, compositions thereof and their use
AP2006003557A0 (en) Antimalarial compositions and process thereof.
IL167936A0 (en) Compounds, compositions,and methods
EP1675834A4 (en) Compounds, compositions, and methods
AU2003225672A1 (en) Copolycarbonate compositions, and related articles and processes
EP1680420A4 (en) Compounds, compositions, and methods
EP1620092A4 (en) Compounds, compositions, and methods
AU2003300031A8 (en) Compounds, compositions, and methods
AU2003267169A8 (en) Compounds, compositions and methods
EP1706111A4 (en) Compounds, compositions and methods